Working…
ClinicalTrials.gov

Key Record Dates

ClinicalTrials.gov Identifier: NCT04743661
Brief Title: 131I-Omburtamab, in Recurrent Medulloblastoma and Ependymoma

First Submitted : February 3, 2021
First Submitted that Met QC Criteria : February 3, 2021
First Posted : February 8, 2021

Last Update Submitted that Met QC Criteria : February 3, 2021
Last Update Posted : February 8, 2021